 This allows the incentive for investing in a particular disease to be independent of the price at which any developed products will be sold.To date, DND"i" has delivered eight new treatments and built a large drug pipeline for neglected diseases with both improvements on existing drugs and entirely new chemical entities.Treatments delivered to date